Owens & Minor (NYSE:OMI) Reaches New 52-Week Low – Time to Sell?

Owens & Minor, Inc. (NYSE:OMIGet Free Report) reached a new 52-week low during trading on Tuesday . The company traded as low as $7.24 and last traded at $7.23, with a volume of 91602 shares changing hands. The stock had previously closed at $7.45.

Wall Street Analyst Weigh In

A number of research firms recently commented on OMI. Citigroup dropped their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a report on Tuesday, November 5th. Barclays dropped their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. UBS Group decreased their target price on Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, Robert W. Baird decreased their target price on Owens & Minor from $15.00 to $14.00 and set a “neutral” rating for the company in a research note on Tuesday, February 4th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $16.79.

Get Our Latest Report on Owens & Minor

Owens & Minor Trading Down 6.8 %

The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The stock has a market capitalization of $491.73 million, a price-to-earnings ratio of -9.81, a PEG ratio of 0.20 and a beta of 0.48. The business has a 50 day simple moving average of $12.38 and a 200-day simple moving average of $13.64.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of OMI. Coliseum Capital Management LLC boosted its position in shares of Owens & Minor by 31.3% during the fourth quarter. Coliseum Capital Management LLC now owns 4,785,964 shares of the company’s stock worth $62,553,000 after buying an additional 1,141,483 shares during the period. Freestone Grove Partners LP acquired a new position in shares of Owens & Minor during the fourth quarter worth about $5,125,000. Foundry Partners LLC acquired a new position in shares of Owens & Minor during the third quarter worth about $5,238,000. Charles Schwab Investment Management Inc. boosted its position in shares of Owens & Minor by 13.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock worth $30,127,000 after buying an additional 276,807 shares during the period. Finally, Deutsche Bank AG boosted its position in shares of Owens & Minor by 77.0% during the fourth quarter. Deutsche Bank AG now owns 495,111 shares of the company’s stock worth $6,471,000 after buying an additional 215,455 shares during the period. 98.04% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Company Profile

(Get Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Recommended Stories

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.